Innovation in Pharmacovigilance: Use of Artificial Intelligence in Adverse Event Case Processing-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Innovation in Pharmacovigilance: Use of Artificial Intelligence in Adverse Event Case Processing

Published:2018-12-11 Issue:4 Volume:105 Page:954-961
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Schmider Juergen¹,Kumar Krishan²,LaForest Chantal³,Swankoski Brian⁴,Naim Karen⁵,Caubel Patrick M.⁶

Affiliation:

1. Pfizer R&D Lake Forest Illinois USA

2. Pfizer Business TechnologyArtificial Intelligence Center of Excellence La Jolla California USA

3. Pfizer Global Product DevelopmentSafety Solutions Kirkland Quebec, Ontario Canada

4. Pfizer Finance and Business Operations Peapack New Jersey USA

5. Pfizer R&D Collegeville Pennsylvania USA

6. Pfizer R&D New York New York USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1255

Reference27 articles.

1. Navitas Life Sciences PVNET Benchmark Survey 2016.

2. Postmarketing Drug Safety Surveillance Using Publicly Available Health-Consumer-Contributed Content in Social Media

3. Prognostic models based on patient snapshots and time windows: Predicting disease progression to assisted ventilation in Amyotrophic Lateral Sclerosis

4. Learning probabilistic phenotypes from heterogeneous EHR data

5. A probabilistic topic model for clinical risk stratification from electronic health records

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial intelligence integration in the drug lifecycle and in regulatory science: policy implications, challenges and opportunities;Frontiers in Pharmacology;2024-08-02

2. A machine learning case study to predict rare clinical event of interest: imbalanced data, interpretability, and practical considerations;Journal of Biopharmaceutical Statistics;2024-06-11

3. Potential Applications of Artificial Intelligence (AI) in Managing Polypharmacy in Saudi Arabia: A Narrative Review;Healthcare;2024-04-05

4. Data-Driven Identification of Factors That Influence the Quality of Adverse Event Reports: 15-Year Interpretable Machine Learning and Time-Series Analyses of VigiBase and QUEST;JMIR Medical Informatics;2024-04-03

5. Navigating duplication in pharmacovigilance databases: a scoping review;BMJ Open;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3